ArticleJournal of cellular and molecular medicine2021

Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.

Yi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.